Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Observational Study to Evaluate Medication-taking Behavior With Denosumab (Prolia) and Patient Characteristics in Postmenopausal Women With Osteoporosis in Routine Clinical Practice in Germany, Austria, Greece and Belgium

NCT01668589 is registered in ClinicalTrials.gov with Amgen as lead sponsor.

NCT NCT01668589
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01668589 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Observational Study to Evaluate Medication-taking Behavior With Denosumab (Prolia) and Patient Characteristics in Postmenopausal Women With Osteoporosis in Routine Clinical Practice in Germany, Austria, Greece and Belgium
Lead sponsor
Amgen
Phase
Observational
Overall status
Completed
Start date
November 28, 2011
Completion date
August 31, 2015
Enrollment
1,501 (actual)
Sites
144

Conditions

As the registry lists them; a condition with its own page is linked.

postmenopausal osteoporosis